New Cancer Injection Shrinks Metastatic Tumors Systemically
Cancer immunotherapy has produced some of medicine’s most dramatic success stories over the past decade. But for every patient whose tumors vanish, several others see little or no benefit. One class of drugs in particular, called CD40 agonist antibodies, promised to supercharge the immune system’s ability to hunt and destroy cancer cells. For more than…
